Sai Life Sciences Ltd.

₹1,395.3

-0.6 (0%)

SAILIFE Share Price

Pharmaceuticals & Biotechnology

As on October 23, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 29,652.7 Cr

P/E Ratio84.69

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,394.02	Bullish
10-DMA	1,421.84	Bearish
20-DMA	1,487.54	Bearish
50-DMA	1,509.91	Bearish
100-DMA	1,383.43	Bullish
200-DMA	1,181.83	Bullish

Historical Performance

1 Year

56.4%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	21,925	16,946	14,652	12,171	8,696
Total Expenditure	15,850	12,867	11,780	10,482	7,447
Other Income	744	368	291	280	281
Operating Profit	6,819	4,446	3,162	1,969	1,530
Interest	409	783	876	810	532
Depreciation	1,669	1,386	1,194	994	902
Profit Before Tax	4,662	2,277	1,092	164	97
Consolidated Net Profit	3,489	1,701	828	100	62
Adjusted EPS	16	8	5	---	---

Compounded Sales Growth

10 Years:38.8

5 Years:23.6

3 Years:12.5

TTM:5.3

Compounded Profit Growth

10 Years:58.4

5 Years:41.7

3 Years:103.5

TTM:15.4

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:55.9

Return on Equity

10 Years:3.4

5 Years:0.4

3 Years:4.7

last year:16.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	212	208	180	180	179
Total Reserves	24,580	21,024	9,465	8,606	8,519
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	3,217	3,216	5,936	5,316	5,654
Other Current Liabilities	4,070	2,626	2,188	1,674	1,028
Short Term Borrowings	696	1,286	3,743	3,720	4,041
Total Liabilities	37,099	32,091	23,087	21,786	21,585
Capital Work in Progress	2,705	1,245	1,069	1,510	1,887
Long Term Loans & Advances	909	626	738	236	500
Currents Investments	470	---	---	---	---
Short Term Loans and Advances	7,280	5,348	3,922	4,019	4,210
Total Current Assets	14,814	15,312	9,451	9,640	9,454
Total Assets	37,099	32,091	23,087	21,786	21,585
Adjusted Book Value	117	102	55	50	50

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 84.69, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 82.5%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹6819 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹21925 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1558907.3

No. of Shares: 1117 (Approx)

Performance:55.9%

558907.3

NIFTY Performance: -12.4%

1 day Top Gainers